Michael House, MD was awarded a grant through the highly competitive Federal Small Business Technology Transfer (STTR) Program. These grants are awarded to domestic small businesses to engage in Federal Research/Research and Development (R/R&D) with the potential for commercialization. Dr. House’s grant is entitled “A novel device for cervical insufficiency in pregnant women.” Cervical insufficiency is a significant pregnancy complication leading to preterm birth, as well as long-term morbidity and mortality of newborn infants. This STTR will develop an innovative medical device to treat cervical insufficiency with improved efficacy and fewer complications compared with traditional cerclage. An effective, alternate treatment for cervical insufficiency will have a significant impact on clinical efforts to prevent preterm birth where cervical insufficiency is the cause. The research in this project is supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under award number R41HD102268. Read more about Dr. House’s research focus here.